Metagenomi Inc. Common St... (MGX)
NASDAQ: MGX
· Real-Time Price · USD
1.87
-0.03 (-1.58%)
At close: Aug 15, 2025, 3:59 PM
1.84
-1.60%
After-hours: Aug 15, 2025, 07:49 PM EDT
Metagenomi Common Stock Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
Revenue | 8.51M | 4.13M | 9.61M | 11.51M | 20.01M | 11.16M | 12.4M | 12.36M | 11.34M | 8.66M | 5.59M | 4.91M | 3.35M | 3.35M |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | 1.27M | 1.2M | -18.14M | 1.01M | 20.13M | 719K | 492K | 8.43M | 8.43M |
Gross Profit | 8.51M | 4.13M | 9.61M | 11.51M | 20.01M | 11.16M | 12.4M | 30.5M | 10.33M | -11.47M | 4.88M | 4.42M | -5.08M | -5.08M |
Operating Income | -20.99M | -27.82M | -20.62M | -22.38M | -16.86M | -29.03M | -20.2M | -22.39M | -17.96M | -17.94M | -15.77M | -10.88M | -9M | -9M |
Interest Income | 2.48M | 2.89M | 3.2M | 3.62M | 3.98M | 3.93M | 3.63M | 3.87M | 3.97M | 4M | 1.93M | 1.08M | n/a | n/a |
Pretax Income | -19.86M | -24.94M | -24.61M | -20.88M | -12.94M | -25.15M | -16.57M | -18.61M | -11.11M | -13.94M | -13.78M | -9.75M | -8.75M | -8.75M |
Net Income | -19.91M | -25.04M | -23.4M | -18.77M | -10.74M | -25.15M | -19.29M | -19.82M | -13.01M | -16.13M | -14.63M | -10.38M | -9.29M | -9.29M |
Selling & General & Admin | 6.99M | 6.8M | 7.07M | 7.64M | 8.55M | 8.75M | 7.84M | 7.92M | 6.62M | 6.46M | 5.58M | 4.07M | 3.92M | 3.92M |
Research & Development | 22.51M | 25.14M | 23.16M | 26.26M | 28.32M | 31.44M | 24.75M | 26.84M | 22.68M | 20.13M | 15.06M | 11.23M | 8.43M | 8.43M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -1.2M | -1.15M | 16K | -1K | n/a | n/a | -8.43M | -8.43M |
Operating Expenses | 29.5M | 31.95M | 30.24M | 33.9M | 36.87M | 40.19M | 31.39M | 33.6M | 29.3M | 26.59M | 20.64M | 15.3M | 3.92M | 3.92M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -719K | -492K | n/a | n/a |
Cost & Expenses | 29.5M | 31.95M | 30.24M | 33.9M | 36.87M | 40.19M | 32.59M | 34.76M | 29.3M | 26.59M | 21.36M | 15.79M | 12.34M | 12.34M |
Income Tax Expense | 44K | 98K | -1.21M | -2.11M | -2.2M | n/a | 2.73M | 1.21M | 1.9M | 2.2M | 846K | 631K | 546K | 546K |
Shares Outstanding (Basic) | 37.16M | 37.02M | 37.09M | 36.77M | 37.46M | 37.47M | 37.47M | 37.47M | 37.47M | 29.96M | 37.47M | 37.47M | 5.93M | 5.93M |
Shares Outstanding (Diluted) | 37.16M | 37.02M | 37.09M | 36.77M | 37.46M | 37.47M | 37.47M | 37.47M | 37.47M | 29.96M | 37.47M | 37.47M | 5.93M | 5.93M |
EPS (Basic) | -0.54 | -0.68 | -0.63 | -0.51 | -0.29 | -0.67 | -0.51 | -0.53 | -0.35 | -0.54 | -0.39 | -0.28 | -1.57 | -1.57 |
EPS (Diluted) | -0.54 | -0.68 | -0.63 | -0.51 | -0.29 | -0.67 | -0.51 | -0.53 | -0.35 | -0.54 | -0.39 | -0.28 | -1.57 | -1.57 |
EBITDA | -19.65M | -26.46M | -19.16M | -21.02M | -15.55M | -27.76M | -15.37M | -17.46M | -16.95M | -17.1M | -13.06M | -9.26M | -8.74M | -8.74M |
EBIT | -20.99M | -27.82M | -20.62M | -22.38M | -16.86M | -29.03M | -16.57M | -18.61M | -17.96M | -17.94M | -13.78M | -9.75M | -9M | -9M |
Depreciation & Amortization | 1.33M | 1.36M | 1.46M | 1.36M | 1.31M | 1.27M | 1.2M | 1.15M | 1.01M | 841K | 719K | 492K | 261K | 261K |